CAD 0.03
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - CAD | -100.0% |
2022 | 22.37 Thousand CAD | -66.68% |
2021 | 67.15 Thousand CAD | -1.8% |
2020 | 68.38 Thousand CAD | 13.38% |
2019 | 60.31 Thousand CAD | -33.01% |
2018 | 90.04 Thousand CAD | 0.0% |
2017 | - CAD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | - CAD | 0.0% |
2024 Q1 | - CAD | 0.0% |
2023 Q3 | 630.00 CAD | 157.14% |
2023 FY | - CAD | -100.0% |
2023 Q4 | - CAD | -100.0% |
2023 Q2 | 245.00 CAD | -98.35% |
2023 Q1 | 14.8 Thousand CAD | -33.83% |
2022 Q3 | 29.59 Thousand CAD | -60.11% |
2022 FY | 22.37 Thousand CAD | -66.68% |
2022 Q1 | 83.61 Thousand CAD | 24.51% |
2022 Q2 | 74.19 Thousand CAD | -11.26% |
2022 Q4 | 22.37 Thousand CAD | -24.4% |
2021 Q2 | 90.07 Thousand CAD | -1.63% |
2021 Q1 | 91.56 Thousand CAD | 33.9% |
2021 Q4 | 67.15 Thousand CAD | -21.24% |
2021 Q3 | 85.26 Thousand CAD | -5.34% |
2021 FY | 67.15 Thousand CAD | -1.8% |
2020 Q1 | 61.15 Thousand CAD | 1.39% |
2020 FY | 68.38 Thousand CAD | 13.38% |
2020 Q4 | 68.38 Thousand CAD | -19.05% |
2020 Q3 | 84.48 Thousand CAD | 13.21% |
2020 Q2 | 74.62 Thousand CAD | 22.03% |
2019 FY | 60.31 Thousand CAD | -33.01% |
2019 Q1 | 59.41 Thousand CAD | -34.01% |
2019 Q2 | 69.43 Thousand CAD | 16.87% |
2019 Q4 | 60.31 Thousand CAD | -17.02% |
2019 Q3 | 72.68 Thousand CAD | 4.68% |
2018 FY | 90.04 Thousand CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 Q4 | 90.04 Thousand CAD | 0.0% |
2017 FY | - CAD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
AI/ML Innovations Inc. | 2854.00 CAD | 100.0% |
Diagnamed Holdings Corp. | -55.31 CAD | 100.0% |
Pangenomic Health Inc. | - CAD | NaN% |
Treatment.Com International Inc. | - CAD | NaN% |
Unidoc Health Corp. | 32.34 Thousand CAD | 100.0% |